ICYMI:
$TRI received $3.5m in second-tranche placement funding, strengthening its balance sheet and advancing Stabl-Im toward the clinic. Stabl-Im enables early, safe, non-invasive detection of brain tumours using stable isotope labelling and standard MRI.
announcements.asx.com.au/asx…